Zurich Cantonal Bank
NUVB icon

Zurich Cantonal Bank’s Nuvation Bio NUVB Stock Holding History

Zurich Cantonal Bank’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,050
Closed -$386K – 3184
2025
Q4 		$386K Buy
+43,050
New +$267K ﹤0.01% 1923

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Zurich Cantonal Bank's NUVB Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Nuvation Bio (NUVB) in Q1 2026: 50,230 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #2225 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in NUVB as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in NUVB in Q2 2021 and has held it in 17 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Zurich Cantonal Bank held 50,230 shares of Nuvation Bio worth $215K as of Q1 2026.
  • Nuvation Bio was a new Zurich Cantonal Bank position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2225 holding.
  • Zurich Cantonal Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 17 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.